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Summary The ability of a highly sensitive gel immunodiffusion technique to detect faecal occult blood in
control subjects and in patients with colorectal carcinoma, was compared to that of Hemoccult II.
In 1,200 samples from 200 control subjects, 3.3% were positive by the immunological technique, 5.0% by
Hemoccult II with rehydration and 2.3% without rehydration, representing 7.5%, 10.5% and 5.0% of
subjects, respectively. A total of 2 carcinomas and 6 polyps were detected in the 27 positive subjects. False
positive results were 4.5% for the immunological technique, 7.5% and 3.0% for Hemoccult II with and
without rehydration.
All 40 patients with colorectal carcinoma had at least 1 in 6 samples positive on immunological testing and
79.2% of all samples were positive. With Hemoccult II, without rehydration, 52.1% of samples and 71.8% of
patients were positive. These values increased to 66.3% and 87.5% with rehydration.
It is concluded that:
(i) The proportion of false positive results on immunological testing is low enough to allow screening of
populations for colorectal carcinoma using this technique. (ii) Using 6 faecal samples, this technique detected
bleeding from 100% of colorectal carcinomas in the study.
Screening populations for colorectal carcinoma by
detection of faecal occult blood has been increasing
over the last decade. Faecal blood has been
detected by chemical techniques which depend on
the pseudo-peroxidase activity of haemoglobin.
These techniques are not specific for bleeding from
the gastrointestinal tract, since vegetables with
pseudo-peroxidase activity and dietary animal
haemoglobin and myoglobin can give false positive
reactions (Bassett & Goulston, 1980; Macrae et al.,
1982). Patients are advised to refrain from eating
certain foodstuffs containing pseudo-peroxidases
during stool collection, thereby reducing (but not
eliminating) false positive results. These restrictions
however, are inconvenient and may reduce patient
acceptance.
Some of the commercially available detection kits
have a sensitivity for blood (e.g. about 200mg
Hb lOOg-1 faeces from Hemoccult II (Frommer &
Logue, 1981) which have been chosen to prevent an
excessive number of false positive results. However,
this is achieved at the expense of an increased
number of false negative results as is seen in the
false negative rate of about 30% with Hemoccult II
(Doran & Hardcastle, 1982). The proportion of
false negative results can be diminished by using
kits of higher sensitivity or by preliminary
rehydration of the faecal specimens, but both give
an increased proportion of false positive results
(Frommer & Logue, 1981; Macrae et al., 1982;
Winawer et al., 1980).
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This dilemma could be avoided by the use of
immunological techniques to detect human haemo-
globin in faeces, since these promise to have the
advantages of much greater specificity and sensi-
tivity than the chemical techniques. Accordingly,
a highly sensitive immunological technique for the
detection of faecal human haemoglobin has been
developed. Concentrations of immunologically
reactive faecal human haemoglobin have been
measured in order to determine: (i) whether normal
subjects have high enough concentrations to be
detected by this sensitive assay, thus producing
an unacceptably large proportion of false positive
results in any colorectal cancer screening pro-
gramme using this assay, and (ii) the ability of this
technique to detect bleeding in patients with colo-
rectal carcinoma, in comparison with Hemoccult II.
Materials and methods
Subjects
Two hundred members of the general public (aged
61.6+10.2y) who agreed to take part in bowel
cancer screening studies and 40 patients with
colorectal carcinomas (aged 67.0+12.1y), collected
6 faecal smears on filter paper from six bowel
actions for immunological testing. During the last
three bowel actions, Hemoccult II cards (containing
two sample windows for each bowel action, giving
a total of 6 samples per card) were also used. In
order to reduce the numbers of false positive results
with Hemoccult II, the subjects were asked to
abstain from eating red meat (but chicken and fish
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were permitted), during the period of stool
collection.
All patients with colorectal carcinoma had been
diagnosed by barium enema (8 patients) or by
colonoscopy (32 patients) and confirmed
histologically, apart from one patient who had a
history of recurrent anaemia and a diagnostic apple
core lesion on barium enema, but did not have a
biopsy. Of the remaining 39 patients, 32 had
biopsies taken after collection of the faecal samples.
In 2 patients, biopsies were taken 12 and 17 days
before stool collections, while in the remainder,
specimens were collected up to 3 days after
biopsies. The sites of the cancers in the 40 patients
were: rectum- 11 cases, sigmoid and descending
colon - 14 cases, transverse colon - 2 cases,
ascending colon and caecum - 13 cases.
Techniques
Hemoccult II cards were developed on the day of
receipt both with rehydration (1 drop of water
30min before development) and without
rehydration. Faecal haemoglobin concentrations
were measured within four days of receipt. The
radial immunodiffusion technique of measuring
faecal haemoglobin concentrations described by
Songster et al. (1980) was used with the following
minor modifications: (i) the use of rabbit instead of
goat antibody to human haemoglobin; (ii) the use
of agarose instead of agar and (iii) the inclusion of
a staining step after the formation of precipitin
rings.
In brief, agarose gel plates were prepared by
adding potassium dihydrogen phosphate buffer
(0.05M, pH8.5), to agarose (Calbiochem) making a
1.15% agarose solution. Rabbit antiserum to
human haemoglobin (Dakopatts, Denmark) was
added to the agarose solution at 56°C to give a
1/20 titre and the agarose mixture poured onto
Gelbond film (FMC Corporation, Rockland,
Maine, USA) to set. Wells of 3mm diameter were
punched out of the gel.
Faeces were smeared onto filter paper and
allowed to air dry. Filter paper discs of 3 mm
diameter and 5,ul of the potassium dihydrogen
phosphate buffer were added to each well.
Standards used with each plate had concentrations
of 2.5-2000mg Hb 100g-1 faeces, freshly prepared
haemolysate being mixed into faeces and smeared
onto filter paper.
Precipitin rings were allowed to develop
overnight for 17h at room temperature and stained
with Coomassie blue (5g1-1). Haemoglobin
concentrations were determined from ring diameters
of standards, a good linear relationship being
obtained between log concentration and diameter.
Adequate precision was obtained with this
technique, coefficients of variation being 4.7% at
2000mg Hb 100g-1 faeces, 5.9% at 250mg Hb
lOOg-1 faeces and 8.7% at 31mg Hb 100-1g
faeces. The limit of detection was 2.0mg Hb
100mg 1 faeces.
Faecal smears showed a marked stability of
haemoglobin concentrations when kept at room
temperature, with a mean fall in detectable
haemoglobin concentration of only 1.75% day-'
and with haemoglobin still detectable after 70 days
(Frommer & Kapparis, 1983a). This technique gave
negative results when tested with blood or meat
from cattle, sheep, pigs and chickens.
Statistical interpretation
Chi-square analysis (with Yates correction) was
used to determine the significance of difference in
proportions.
Results
Table I shows the proportion of control subjects
with positive results on testing immunologically,
with and without rehydration of Hemoccult II. The
proportion of all the subjects positive on
immunological testing (7.5%), was between that of
Hemoccult II testing with (10.5%) and without
(5.0%) faecal rehydration. Investigation of the 15
subjects with positive results on immunological
testing, (Table II) showed that 2 had carcinomas
and 4 had polyps. The proportion of true positive
results (carcinomas and polyps) was similar for
immunological and rehydrated Hemoccult II
techniques (3%) and greater than that for
Hemoccult II with rehydration (2%). However,
both for samples and subjects the proportion of
false positive results from Hemoccult II with
rehydration was greater than without rehydration
(P<0.0025 and P<0.05) and also greater than with
the immunological technique (P<0.05 and
P=0.20).
All 40 patients with colorectal cancer (Table III)
had positive samples on immunological testing.
Table I Total number of samples and subjects positive in
control group.
Hemoccult II
Not-rehydrated Rehydrated Immunological
Samples 27/100 60/1200 40/1200
(2.3%) (5.0%) (3.3%)
Subjects 10/200 21/200 15/200
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Table II Investigation of control subjects with positive
results
No
abnormality
Carcinoma Polyps detected Total
Hemoccult II
Not-rehydrated 1 3 6 10
Rehydrated 1 5 15 21
Immunological 2 4 ga 15
aOne subject had colonic telangiectases but was
regarded as a false positive result.
Table In Positive results in 40 patients with colorectal
carcinoma
Hemoccult II
Not-rehydrated Rehydrated Immunological
Samples 122/234a 159/240 190/240
(52.1%) (66.3%) (79.2%)
Patients 28/39a 35/40 40/40
(71.8%) (87.5%) (100%)
aOne patient did not submit samples on Hemoccult II
card for testing without rehydration.
Hemoccult II without rehydration detected blood in
only 71.8% of the patients, and the proportion
(52.1%) of positive samples was less than that on
immunological testing (79.2%). Rehydration of
samples increased the proportion of positive results
for both patients (87.5%) and faecal samples
(66.3%) but not to the levels found on
immunological testing.
There was no range of haemoglobin concentra-
tions which predominated in the positive samples,
although few positive samples were above 1000mg
Hb 100mg-1 faeces. Concentrations of 2.0-10.0mg
Hb lOOg-1 faeces were found in 35 (14.6%) of
positive specimens (in 16 patients), and 33 (13.8%)
specimens in 20 patients had concentrations of
10.0-50.0mg Hb lOOg-1 faeces. The percentage
of faecal samples from patients with colorectal
carcinoma that were positive at or above various
concentrations of faecal haemoglobin is shown in
Figure 1. There was a close inverse relationship
between these two parameters. Extrapolation of
the regression line to the vertical axis suggests that
100% of faecal samples would be positive at
0.47mg Hb lOOg-1 faeces limit of sensitivity. The
effect of the number of stool samples on the
proportion of patients having all samples negative
on immunological testing (i.e. giving false negative
results) is shown on Table IV. Results from various
combinations of consecutive stool sample ("blocs")
with 1-6 samples were taken from each patient and
the results of all patients summed. For example,
providing 6 samples could have 3 combinations or
blocs of 4 samples i.e. 1-4, 2-5 and 3-6 inclusively.
It can be seen that a false negativity rate of zero
for patients with colorectal carcinoma was achieved
with six faecal samples.
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Figure 1 Percentage of samples positive versus mini-
mum concentrations offaecal haemoglobin detected. (Y
intercept=91.6; Correlation coefficient (r)= -0.99).
Table IV False negative rates for immunological testing for faecal human
haemoglobin in colorectal cancer patients related to the number of faecal
samples tested
Number of consecutive
samples in a "bloc" 1 2 3 4 5 6
Number of blocs with
all samples negative 48 20 9 2 1 0
Number of blocs 240 200 160 120 80 40
% of blocs with all
samples negative 20.0 10.0 5.63 1.67 1.25 0
c
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Discussion
Many tests for diseases have sensitivities which are
inversely related to their specificities, so that the
greater the proportion of cases of the disease giving
an abnormal result on the test, the larger the
number of false positive results obtained. The
detection of occult blood using chemical techniques
in screening for colorectal cancer also shares this
difficulty but the use of immunological techniques
suggests that sensitivity can be markedly increased
with only a slight increase in proportion of false
positive results.
Six samples were chosen for analysis by the
immunological technique to make the comparison
with six samples on a Hemoccult II card as valid as
possible. The immunological technique resulted in
15/200 (7.5%) control subjects giving a positive
result. Investigations showed a probable cause of
bleeding in 6 subjects leaving 9 (4.5%) with false
positive results, (although one subject had colonic
telangiectases). This value is close to the value of
3.9% found in 76 younger (22-42y) volunteers
(Frommer & Kapparis, 1983b). This suggests that
the frequency of false positive results with this
technique does not rise markedly with age. The
cause of false positive results in this study may be
haemorrhoids, other anal pathology or small polyps
and telangiectases missed on colonoscopy. The
proportion of 4.5% of subjects with false positive
results on immunological testing was only slightly
higher than that for Hemoccult II without
rehydration and would be small enough to enable
follow-up investigations to be undertaken in mass
screening programmes. Another study (Macrae et
al., 1982) involving young volunteers (22.1 +4.4y)
on a meat free diet, showed that false positive rates
with Hemoccult II increase from 0% to 5.7% by
rehydrating faecal samples, these values both being
lower than that found for the control group in this
study. A diet with a lower peroxidase content,
greater adherence to the diet or the lower incidence
of anal pathology may all have contributed to the
lower positivity rate in the younger population.
The incidence of 1% carcinomas in the control
population is much higher than has been found in
most screened (and mainly asymptomatic) popu-
lations where the incidence has varied between
0.02% and 0.72%. The causes of this may be the
greater sensitivity of the immunological technique
for demonstrating occult blood, more scrupulous
follow-up investigations of positive cases, a greater
proportion of subjects with symptoms and/or
family history of bowel neoplasms or an older age
group. However, one can draw no conclusions from
such a comparatively small number of subjects and
additional data on incidence of carcinoma in
screened populations will have to await evaluation
of a larger series. The percentage of subjects in the
control group with false negative results for
carcinomas and polyps may be the same as in the
patient group, but this study cannot give any
information on this point. This information is being
sought in a separate study, to be published later.
The proportion of patients with carcinomas with
detectable blood loss is very similar to other studies
using Hemoccult II without and with preliminary
rehydration. The sensitivity of the techniques used
for detecting blood loss from carcinoma was in the
order: immunological >rehydrated>not rehydrated
Hemoccult II for both samples and patients.
Analysis of the immunological data showed that the
more sensitive the detection system, the greater the
proportion of faecal samples being positive in a
predictable manner. From Figure I it can be seen
that a limit of sensitivity of 30mg Hb 1OOg -
faeces would result in 53.9% of samples being
positive. Songster et al. (1980) obtained 67%
positivity at this detection limit. Extrapolation of
the regression line in Figure 1 suggests that 100%
of faecal samples would be positive with a detection
limit of about 0.5mg Hb lOOg-1 faeces, but it is
doubtful whether the sensitivity of this system
could be increased to this degree.
Fewer positive results are obtained with very
small samples because inhomogeneity of blood
distribution in the faecal mass results in some areas
having much lower than average concentrations.
Samples from such areas may be below the limit of
detection despite the average concentration being
above the limit. Sensitivity of detecting occult blood
can be increased markedly by homogenising faeces
prior to taking small samples e.g. 1-5mg, for
analysis. A similar immunodiffusion technique with
a detection limit of 5mg Hb lOOg-1 faeces, but
using solutions of homogenised faeces, had 40/40
samples and 14/14 patients positive from
carcinomas involving the colon (Williams et al.,
1982). An ELISA technique with a detection limit
of 5-10mg Hb lOOg-1 faeces, using homogenised
48 h faecal samples from patients with colorectal
carcinoma had 93% (28/30) samples and 95%
(18/19) patients positive (Turunen et al., 1984).
Homogenisation of samples of I g or more of
faeces, may be useful with hospital patients and
some outpatients, but the inconvenience and loss of
immunological reactivity of about 58-71% day-'
(Frommer & Kapperis, 1983a) make it less suitable
for mass screening of medium-risk subjects. Faecal
samples smeared immediately onto filter paper
however, show a loss of reactivity of less than 2.5%
day-1 (Frommer & Kapparis, 1983a). Increase in
sensitivity for bleeding from colorectal carcinoma
using homogenised samples was also associated
with higher positive rates for control subjects, 3/19
(16%) (Williams et al., 1982).OCCULT BLOOD DETECTION IN BOWEL CANCER 861
In this study it can be demonstrated that 21% of
samples of the 40 patients with colorectal
carcinoma were negative with the immunological
technique. From this it might be deduced that a
false negative rate of < 1% (0.21) may be achieved
by testing three samples (Frommer & Kapparis,
1983a). However this involves the assumption that
each patient has the same likelihood of 21% of
false negative samples, and this did not occur as the
proportion of false negative results varied
markedly. Table IV shows that 6 samples would be
needed to reduce the chance of a false negative
result to <1%, assuming these data apply to the
general cancer population. We have found that the
demand for samples from 6 bowel actions instead
of 3, as with Hemoccult II, did not reduce patient
compliance.
The optimal number of samples to be provided
depends on the level of false negative results for
carcinoma that is acceptable, the proportion of
adenomas (which bleed less than carcinomas) that
one wishes to detect, the proportion of false
positive results that is acceptable, and the cost of
testing samples. The costs of the immunological
technique are of the same order as Hemoccult II
and the time taken to carry it out 'en masse' is
about 5 minutes per subject. The data presented
suggests that immunological testing for human
blood in faeces is superior to chemical techniques
for screening for colorectal cancer.
The authors wish to acknowledge the helpful advice of Dr
G. Barrows.
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